HK1010881A1 - Derivatives of azetidine and pyrrolidine - Google Patents
Derivatives of azetidine and pyrrolidineInfo
- Publication number
- HK1010881A1 HK1010881A1 HK98112152A HK98112152A HK1010881A1 HK 1010881 A1 HK1010881 A1 HK 1010881A1 HK 98112152 A HK98112152 A HK 98112152A HK 98112152 A HK98112152 A HK 98112152A HK 1010881 A1 HK1010881 A1 HK 1010881A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- alkoxy
- alkyl
- naphth
- pyrrolidin
- oxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97200536A EP0863136B1 (en) | 1997-02-25 | 1997-02-25 | Derivatives of azetidine and pyrrolidine |
PCT/EP1998/001282 WO1999043647A1 (en) | 1997-02-25 | 1998-02-26 | Derivatives of azetidine and pyrrolidine |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1010881A1 true HK1010881A1 (en) | 1999-07-02 |
Family
ID=8228047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98112152A HK1010881A1 (en) | 1997-02-25 | 1998-11-20 | Derivatives of azetidine and pyrrolidine |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0863136B1 (xx) |
AT (1) | ATE250573T1 (xx) |
AU (1) | AU754745B2 (xx) |
DE (1) | DE69725113T2 (xx) |
DK (1) | DK0863136T3 (xx) |
ES (1) | ES2208812T3 (xx) |
HK (1) | HK1010881A1 (xx) |
PT (1) | PT863136E (xx) |
WO (1) | WO1999043647A1 (xx) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ503626A (en) | 1997-11-05 | 2002-05-31 | Neurosearch As | Azaring-ether derivatives and their use as nicotinic ACh receptor modulators |
JP2002526443A (ja) | 1998-09-18 | 2002-08-20 | アルコン ラボラトリーズ, インコーポレーテッド | 緑内障治療用セロトニン作動性5ht2作用物質 |
US6465467B1 (en) | 1999-05-21 | 2002-10-15 | Biovitrum Ab | Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
SE0004245D0 (sv) | 2000-11-20 | 2000-11-20 | Pharmacia Ab | Novel compounds and their use |
EP1337518B1 (en) | 2000-11-20 | 2009-06-17 | Biovitrum AB (publ) | Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor |
EP1213017A3 (en) * | 2000-12-05 | 2003-11-12 | Akzo Nobel N.V. | Use of a 5-HT2C receptor agonist for the treatment of hot flushes |
US6498184B2 (en) | 2000-12-05 | 2002-12-24 | Akzo Nobel N.V. | Serotonergic compound for a method of treatment of hot flushes in post-menopausal women |
AU2003243089B2 (en) | 2002-06-19 | 2010-01-07 | Biovitrum Ab (Publ) | Novel compounds, their use and preparation |
CN100354264C (zh) * | 2002-07-22 | 2007-12-12 | 旭化成制药株式会社 | 5-取代异喹啉衍生物及含有它们的药物 |
US7094789B2 (en) | 2002-07-22 | 2006-08-22 | Asahi Kasei Pharma Corporation | 5-substituted isoquinoline derivatives |
CL2004000826A1 (es) | 2003-04-25 | 2005-03-04 | Pfizer | Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129 |
US20070021404A1 (en) * | 2003-06-24 | 2007-01-25 | Dan Peters | Novel aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
WO2006022420A1 (ja) | 2004-08-25 | 2006-03-02 | Takeda Pharmaceutical Company Limited | 腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法 |
JP4318744B2 (ja) | 2005-03-31 | 2009-08-26 | ファイザー・プロダクツ・インク | シクロペンタピリジンおよびテトラヒドロキノリン誘導体 |
WO2007132841A1 (ja) | 2006-05-16 | 2007-11-22 | Takeda Pharmaceutical Company Limited | 縮合複素環化合物およびその用途 |
US8748419B2 (en) | 2006-06-16 | 2014-06-10 | Theracos, Inc. | Treating obesity with muscarinic receptor M1 antagonists |
US7893053B2 (en) | 2006-06-16 | 2011-02-22 | Theracos, Inc. | Treating psychological conditions using muscarinic receptor M1 antagonists |
NZ582273A (en) | 2007-06-06 | 2011-06-30 | Torrent Pharmaceuticals Ltd | Thyroid like compounds |
US20100266504A1 (en) | 2007-11-15 | 2010-10-21 | Takahiro Matsumoto | Condensed pyridine derivative and use thereof |
FR2925050B1 (fr) * | 2007-12-14 | 2010-01-08 | Sanofi Aventis | Nouveau procede de preparation de derives d'azetidine |
KR101062376B1 (ko) | 2008-04-10 | 2011-09-06 | 한국화학연구원 | 신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물 |
WO2010059393A1 (en) | 2008-10-30 | 2010-05-27 | Janssen Pharmaceutica Nv | Serotonin receptor modulators |
US8575364B2 (en) | 2008-10-30 | 2013-11-05 | Janssen Pharmaceutica Nv | Modulators of serotonin receptor |
JPWO2011071136A1 (ja) | 2009-12-11 | 2013-04-22 | アステラス製薬株式会社 | 線維筋痛症治療剤 |
WO2012030953A1 (en) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level |
KR101426408B1 (ko) * | 2013-02-19 | 2014-08-07 | 한국과학기술연구원 | 4각 고리 질소 화합물, 이를 포함하는 우울증, 정신 질환, 조루증, 또는 신경병증성 통증의 예방 또는 치료용 약학 조성물, 및 상기 약학 조성물을 포함하는 제제 |
WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
CN105237381A (zh) * | 2015-10-14 | 2016-01-13 | 湖南华腾制药有限公司 | 5-羟基-1-茚酮的制备方法 |
CN105330525A (zh) * | 2015-10-25 | 2016-02-17 | 湖南华腾制药有限公司 | 7-羟基-1-茚酮的制备方法 |
WO2019131902A1 (ja) | 2017-12-27 | 2019-07-04 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2085427B (en) * | 1980-10-08 | 1984-12-05 | Robins Co Inc A H | 3-phenoxyazetidines |
DE3835291A1 (de) * | 1988-04-19 | 1989-11-02 | Bayer Ag | 1,3-disubstituierte pyrrolidine |
US5130309A (en) * | 1991-04-12 | 1992-07-14 | A. H. Robins Company, Incorporated | Aryloxy and aryloxyalklazetidines as antiarrhythmic and anticonvulsant agents |
-
1997
- 1997-02-25 ES ES97200536T patent/ES2208812T3/es not_active Expired - Lifetime
- 1997-02-25 EP EP97200536A patent/EP0863136B1/en not_active Expired - Lifetime
- 1997-02-25 AT AT97200536T patent/ATE250573T1/de active
- 1997-02-25 DE DE69725113T patent/DE69725113T2/de not_active Expired - Lifetime
- 1997-02-25 DK DK97200536T patent/DK0863136T3/da active
- 1997-02-25 PT PT97200536T patent/PT863136E/pt unknown
-
1998
- 1998-02-26 WO PCT/EP1998/001282 patent/WO1999043647A1/en active IP Right Grant
- 1998-02-26 AU AU65002/98A patent/AU754745B2/en not_active Ceased
- 1998-11-20 HK HK98112152A patent/HK1010881A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU6500298A (en) | 1999-09-15 |
DE69725113D1 (de) | 2003-10-30 |
AU754745B2 (en) | 2002-11-21 |
EP0863136A1 (en) | 1998-09-09 |
DK0863136T3 (da) | 2004-02-02 |
DE69725113T2 (de) | 2004-07-15 |
WO1999043647A1 (en) | 1999-09-02 |
EP0863136B1 (en) | 2003-09-24 |
PT863136E (pt) | 2004-01-30 |
ATE250573T1 (de) | 2003-10-15 |
ES2208812T3 (es) | 2004-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1010881A1 (en) | Derivatives of azetidine and pyrrolidine | |
CA2321188A1 (en) | Derivatives of azetidine and pyrrolidine | |
CY1105863T1 (el) | Παραγωγα εποθιλονης και η συνθεση και η χρηση τους | |
NZ237565A (en) | Substituted thiazolidinones, oxazolidinones or imidazolidinones and antiinflammatory pharmaceutical compositions thereof | |
DE3750184D1 (de) | Peptidylaminodiole. | |
FI950309A0 (fi) | Proliiniamidijohdannaisia | |
RU2088589C1 (en) | Derivatives of 17 beta-substituted-4-aza-5-5 alpha-androstane-3-ones, methods of synthesis of compounds, pharmaceutical composition, compound 4 | |
DE69803750D1 (de) | Thiazolidinedione- und oxazolidinedione-derivate mit antidiabetischen, hypolipidämischen und anti hypertensiven eigenschaften | |
EP0347252A3 (en) | Method of treating cachexia and certain new compounds for use in this method | |
ES538418A0 (es) | Un derivado de indol-3-carboxamida | |
AU8405891A (en) | Indole derivative and medicine | |
DE69431035D1 (de) | 2-Phenyl-3-Azoylbenzothiophene zur Erhöhung der Thrombomodulin Expression | |
TW221429B (xx) | ||
GB8706662D0 (en) | Anti-arrhythmia agents | |
EP0555479A4 (xx) | ||
HUT70761A (en) | Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof | |
TW275629B (xx) | ||
AU7589298A (en) | 5-{(heteroaryl)alkyl}-3-oxo-pyrido{1,2-(a)}benzimidazole-4-c arboxamide derivatives useful in treating central nervous system disorders | |
BR9815690A (pt) | Composto, processo para a preparação de qualquer um dos compostos, composição farmacêutica, e, uso do composto de 3-(nafter-1-il-óxi) - pirrolidina, 3-(5,6,7,8 - tetraidro-nafterc-1-il-óxi) - pirrolindina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20120225 |